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ABSTRACT
Lapachol is a naphtoquinone with therapeutic potential against enterovirus, Chagas disease and is
also used as an antimalarial and antiinflamatory agent. In order to study teratogenic potential of Lapa-
chol, pregnant Wistar rats were treated with 0.5 ml of distilled water (control group); 0.5 ml of hy-
droalcoholic solution (vehicle group) and 10 mg of Lapachol in 0.5 ml of hydroalcoholic solution
(treated group) by oral gavage from the 8th to the 12th day of pregnancy. The following variables were
observed: maternal body weight on days 1, 6, l5 and 21 and food intake on days 2, 6, 15 and 21 of
pregnancy. The number of live and dead fetuses and the sites of resorptions were counted. The ovaries
were weighed and the corpora lutea were counted. Data were analyzed by ANOVA-one way, Dunnett
test and the chi square test. Significance level test α = 0.05. Results have shown that mothers were
unaffected but there were a 99.2% of fetus mortality, indicative of a strong abortifacient effect of Lapa-
chol in rats.
Key words: Lapachol, embryotoxicity, rat.
RESUMO
Toxicologia do Lapachol em ratas: embrioletalidade
O Lapachol é uma naftoquinona com potencial terapêutico contra enterovírus, doença de Chagas e
como antimalárico. Para estudar o potencial embriotóxico do Lapachol, ratas originalmente Wistar,
grávidas, foram tratadas com 0,5 ml de água destilada (grupo controle); 0,5 ml de solução hidroal-
coólica (grupo veículo) e 10 mg de Lapachol em 0,5 ml de solução hidroalcoólica (grupo tratado)
por gavage, do 8o ao 12o dia de gestação. As seguintes variáveis foram observadas: peso corporal
materno nos dias 1, 6, 15 e 21, consumo de ração nos dias 2, 6, 15 e 21 de gestação. O número de
fetos vivos e mortos e os locais de reabsorção foram contados. Os ovários foram pesados e os corpos
lúteos, contados. Os dados foram analisados por ANOVA “one way”, teste de Dunnet e Qui-quadrado.
O nível de significância dos testes foi α = 0,05. Os resultados mostram que as mães não foram afetadas,
mas ocorreram 99,2% de mortes fetais, o que indica um potente efeito embriotóxico do Lapachol para
o rato.
Palavras-chave: Lapachol, embriotoxicidade, rato.
INTRODUCTION
Lapachol is a naphthoquinone (2-hydroxy-
3-(3-methyl-2 butenil)-1,4 naphthoquinone), ex-
tracted from Pau d’arco (Family Bignoneaceae)
(Santana et al., 1968).
A great spectra of therapeutic activities have
been attributed to Lapachol or its derivatives such
as prevention of cercarial skin penetration of
Schistossoma mansoni (Pinto et al., 1977); trypa-
nosomicidal (Austin, 1974; Lopes et al., 1978),
antiinflammatory (Almeida, 1990) and antineo-
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plasic agents (Santana et al., 1968; Rao, 1974;
Linardi et al., 1975); antimalarial against erytro-
cytic stages of Plasmodium falciparum (Carva-
lho et al., 1988) and use against enteroviruses
(Pinto et al., 1987).
In spite of these therapeutic possibilities, only
a few papers have been published about the toxi-
cology of Lapachol (Santana et al., 1968; Morrison
et al., 1970; Austin, 1974). So it seems important
to screening the toxic effect on embryo after admi-
nistration of Lapachol to rats as a part of the studies
on the toxicology of this phytoterapic.
MATERIAL AND METHODS
Three-month old female Wistar rats, weighing
175 ± 10 g, obtained from the Centro de Biolo-
gia da Reprodução vivarium were maintained in
temperature-controlled quarters with a light – dark
period of 12:12 hs. Food and water were available
ad libitum.
Female rats were caged with fertile male. The
following day was designated day 1 of pregnancy
if spermatozoa or a seminal plug was present in
the vagina.
Inseminated females were randomically assig-
ned to one of the following groups: control, vehicle
or treated.
Animals of control group were treated with
0.5 ml of distilled water; vehicle group was treated
with 0.5 ml of hydroalcoholic solution and the
treated one received 10 mg of 0.5 ml of Lapachol
hydroalcoholic solution. All treatments were done
by oral gavage from the 8th to the 12th day of preg-
nancy – period of greater sensibility to teratogens
in rats (Manson & Kang, 1994).
The dose of Lapachol was calculated on the
basis of the therapeutic doses given to humans (25
mg/kg), and the DL-50 which was 1.600 mg/kg
of rat body weight (Santana et al., 1968).
In order to observe maternal toxic effect,
clinical criteria were adopted (Manson & Kang,
1994) and the following variables were collected:
maternal body weight on days 1, 6, l5 and 21 of
pregnancy; food intake on days 2, 6, 15 and 21
of pregnancy. Locomotor activities, piloerection,
vaginal bleeding and any other unusual behavior
were also observed.
Rats were killed on day 21 of pregnancy by
an overdose of ether inhalation. The uterus of each
animal was exposed and the number of live and
dead fetuses were counted.
The sites of resorption were counted and
recorded. Live and dead fetuses were examined
to detect external malformations.
The ovaries were weighed and the corpora
lutea were counted.
Statistical analysis were performed using
ANOVA-one way Dunnett test and the chi square
test to evaluate continuous and discontinuous data,
respectively. Significance level test was α = 0.05.
The project was approved by CBR ethical
committee.
RESULTS
Rats of all experimental groups had no alte-
ration of locomotor activities and did not present
piloerection. There were no maternal deaths and the
food intake was similar among the groups (Table 1).
No maternal body weight loss was observed
during the gestation period (Table 2).
Mean of implants and corpora lutea were
similar among the experimental groups (Table 3).
The implantation index (total implantation/
total corpora lutea × 100) was 89.8%, 91.8% and
95.4%, in the control, vehicle and Lapachol treated
groups, respectively. There was no significant
difference among the groups.
There were 2%; 0.99% and 99.2% of resorp-
tions and a mean of 10 ± 2 (14); 11 ± 2 (9) and
1.0 live fetus in the control, vehicle and lapachol
treated groups, respectively. There was a high signi-
ficant difference among treated, control and vehicle
groups (p < 0.01).




Since no clinical signs of maternal toxicity
were observed, except for the food intake reduction
in the Lapachol treated rats, it is possible to as-
sume that Lapachol was not toxic to the mothers
considering the dose used (Manson & Kang, 1994).
The reproductive performance of mothers can
be considered normal since the implantation index,
the mean of implants and corpora lutea were si-
milar in all experimental groups.
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The conception index correlates the implan-
tation site and the number of corpora lutea (Ford,
1982) – the higher the index the greater the number
of ovulation that results in oocytes fertilization
and in blastocysts implantation. When the diffe-
rence between corpora lutea and implantation sites
is greater than 10% there is a possibility of repro-
ductive failure (Wilson, 1980).
The development from implanted blastocyst
ongoing is coordinated by a sum of events depen-
ding mostly on the progesterone secreted by cor-
pora lutea.
The blood concentration level of progesterone
was correlated to the number and volume of cor-
pora lutea (Kato et al., 1979), so it is reasonable
to assume that progesterone level can be normal
since the mean number of corpora lutea was si-
milar among experimental groups.
Taken together, the data above mentioned
suggest that the Lapachol treatment did not cause
general or reproductive maternal toxicity.
Except for one mother Lapachol treated that
had one live fetus, all the others presented 99%
of resorbed fetus. Since resorption is an in situ
autolyse of embryos or fetuses (Kalter, 1980) it
is possible to assume that Lapachol is very toxic
to the embryos during the early organogenic period.
As mothers were unaffected, there was a high
incidence of fetal mortality and the single live fetus
was 50% lighter than the control ones, it is possible
Food intake (g)/days of pregnancy
Groups
2 6 15 21
Control 18.77 ± 5.37 (14) 17.05 ± 2.57 (14) 20.46 ± 3.59 (11) 21.37 ± 3.06 (14)
Vehicle 15.78 ± 1.03 (9) 17.78 ± 1.82 (9) 19.77 ± 3.24 (9) 22.36 ± 2.10 (9)
Lapachol 14.50 ± 3.32 (11) 15.06 ± 1.42 (11) 16.47 ± 4.16 (11)* 21.95 ± 2.09 (11)
Results are expressed in  Mean ± SD (n). * p = 0.020.
Maternal weight (g)/days of pregnancy
Groups
1 6 15 21 *
Control 171.54 ± 12.19 (14) 184.45 ± 13.86 (14) 215.86 ± 29.12 (14) 194.69 ± 13.43 (14)
Vehicle 182.83 ± 11.66 (9) 199.48 ± 11.13 (9) 206.01 ± 13.68 (9) 211.10 ± 15.49 (9)
Lapachol 177.17 ± 14.16 (11) 192.92 ± 12.25 (11) 198.76 ± 13.06 (11) 205.44 ± 14.86 (11)
Results are expressed in Mean ± SD (n). * The weight was obtained after uterus, ovaries and conceptuses were removed.
Groups Corpora lutea Implants
Control 12 ± 1 (14) 11 ± 2  (14)
Vehicle 12 ± 1  (9) 11 ± 2  (9)
Lapachol 12 ± 1 (11) 11 ± 1  (11)
Results are expressed in Mean ± SD (n).
TABLE 1
Food intake in control, vehicle and Lapachol (10 mg/rat) treated pregnant rats.
TABLE 2
Body weight (g) in control, vehicle and Lapachol (10 mg/rat) treated pregnant rats.
TABLE 3
 Mean of corpora lutea and implants in control, vehicle and Lapachol (10 mg/rat) treated pregnant rats.
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to assume that the phytoterapic is embryocid and
it is necessary to further evaluate the possibility
of lower doses be teratogenic.
In conclusion, in spite of the great therapeutic
potentiality of Lapachol it is necessary to evaluate
its teratogenic potential and other toxic effects
carefully before the clinical use in humans because
it is a strong abortifacient in rats and the possibility
of it having the same effect in human cannot be
discarded.
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